Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Akoya Biosciences, Inc.

Akoya Biosciences, Inc. (AKYA) Stock Overview

Explore Akoya Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AKYA●NASDAQ
HealthcareMedical - Instruments & Supplies
$1.29
$0.07(5.15%)
U.S. Market opens in 14h 26m

Akoya Biosciences, Inc. (AKYA)

Meyka AI Score

Z

Key Financials

Market Cap64.4M
P/E Ratio-1.15
EPS (TTM)$-0.96
ROE-1.80%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

AKYA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Akoya Biosciences, Inc. (NASDAQ: AKYA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Akoya Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AKYA on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Akoya Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.15 and a market capitalization of 64.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AKYA on the NASDAQ.

Price Performance (NASDAQ: AKYA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
14.16%
6-Month Change
-47.56%
Year-to-Date (YTD) Change
-46.91%
1-Year Change
-34.18%
3-Year Change
-91.41%
5-Year Change
-93.55%
All-Time (Max) Change
-93.55%

Contact Information

https://www.akoyabio.com
855 896 8401
100 Campus Drive, Marlborough, MA, 01752

Company Facts

2,050 Employees
IPO DateApr 16, 2021
CountryUS

Frequently Asked Questions